Eloxx Pharmaceuticals, Inc.

ELOX · OTC
Analyze with AI
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Assets
Cash & Equivalents$19,207$42,268$24,668$22,493
Short-Term Investments$0$0$0$33,783
Receivables$0$0$0$26
Inventory$0$0$0$708
Other Curr. Assets$922$1,212$1,225$742
Total Curr. Assets$20,129$43,480$25,893$57,709
Property Plant & Equip (Net)$994$1,659$554$1,125
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$0$0$30$113
Total NC Assets$994$1,659$584$1,238
Other Assets$0$0$0$0
Total Assets$21,123$45,139$26,477$58,947
Liabilities
Payables$3,020$1,379$481$1,871
Short-Term Debt$4,692$657$5,628$4,835
Tax Payable$0$0$38$43
Deferred Revenue$12,535$3,723$805$403
Other Curr. Liab.$2,844$4,196$2,886$4,655
Total Curr. Liab.$23,091$9,955$9,838$11,807
LT Debt$8,692$12,800$6,409$10,927
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$0$0$0
Total NC Liab.$8,692$12,800$6,409$10,927
Other Liabilities$0$0$0$0
Cap. Leases$847$1,461$422$924
Total Liabilities$31,783$22,755$16,247$22,734
Equity
Pref Stock$0$0$0$0
Common Stock$22$22$404$402
Retained Earnings-$274,388-$238,323-$171,596-$137,019
AOCI$0$0$0$18
Other Equity$263,706$260,685$181,422$172,812
Total Equity-$10,660$22,384$10,230$36,213
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$21,123$45,139$26,477$58,947
Net Debt-$5,823-$28,811-$12,631-$6,731
Eloxx Pharmaceuticals, Inc. (ELOX) Financial Statements & Key Stats | AlphaPilot